In CRC, RANTES not only may directly affect the PD-L1 activity by stabilizing and controlling its deubiquitinating, but is also able to modulate all the components of the tumor microenvironment to promote the immune escape and consequently increase the activity of PD-L1 in the tumor through indirect mechanisms. The gene discussed is CD274; the disease is colorectal carcinoma.